Blocking GLI-1 function in AML cells by using GLI-1antagonist (GANT-61) was investigated by Lau et al., who demonstrated decreased proliferation, growth arrest, and apoptosis in AML cell lines [12, 13]. This evidence concerns the gene GLI1 and acute myeloid leukemia.